Heart Failure


The Practical Cardiology(TM) Heart Failure clinical resource center is an information hub for the latest in heart failure and heart failure management. With a focus on heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF) this page features content including articles, videos, podcasts, and clinician-authored columns on FDA approvals, studies, guideline updates, and more.

Subpar Prescription of Sacubitril/Valsartan Remains a Barrier in Heart Failure Management, With Stephen Greene, MD

August 12, 2021

Data from a major registry suggests more than 90% of patients with heart failure with reduced ejection were discharged from the hospital without being prescribed sacubitril/valsartan (Entresto) and more than 90% of those patients never filled a prescription in the year following hospitalization.

Cardiology Month in Review: July 2021

July 31, 2021

July's month in review features stories related to EMPEROR-Preserved meeting primary endpoint, a Q&A with Javed Butler, MD, on heart failure prevention, comparing ACEs vs ARBs, and more. Check back around the end of each month for the next Cardiology Month in Review.

Donor Hearts from Drug Users Safe for Transplant, Becoming More Common

July 28, 2021

Despite the notion they are unsafe, a pair of studies demonstrate there were no significant differences in outcomes among heart transplant recipients receiving a donor heart based on a history of illicit drug use or overdose.

Q&A on Heart Failure Prevention, with Javed Butler, MD

July 27, 2021

Practical Cardiology sat down with Javed Butler, MD, following his presentation at ASPC 2021 to discuss how recent advances have impacted prevention of heart failure and how he views the role of primary care/internal medicine in primary prevention.

With Implantable Cardioverter-Defibrillators, Every 10-Minute Increase in Physical Activity Reduces Mortality Risk by 1.1%

July 22, 2021

Analysis of more than 40k Medicare beneficiaries suggests increased physical activity, whether it occurs as part of a rehabilitation or not, was associated with decreased risk of all-cause mortality and hospitalizations for heart failure in patients who recently received an implantable cardioverter-defibrillator.